Evaluation of a Mobile Messaging Service in Improving Adherence (Text and /or Graphic/Audio) with Ensured Supply of Anti-seizure Medications in People with Epilepsy in Kilifi and Nairobi, Kenya, EPInA

Kenya, 2023 - 2024
Health and Well-Being (HaW)

Dr Symon Kariuki

Data file: Cost-effectiveness tool

Cases	1799
Variables	257

Variables

cst_q1p1

cst_q1p3

cst_q1p2

caseid

typeofvisit

respondent

income

day_birth

month_birth

year_birth

age_years

assistance

amount

fromwhom

consultations

consultations_other

contact_yesno

contact

contact_1

contact_2

contact_3

contact_4

contact_5

contact_6

repeat1_count

item_1

item_name_1

number_contact_1

money_travelling_1

time_waiting_1

time_travelling_1

time_spent_1

visit_fee_1

item_2

item_name_2

number_contact_2

money_travelling_2

time_waiting_2

time_travelling_2

time_spent_2

visit_fee_2

item_3

item_name_3

number_contact_3

money_travelling_3

time_waiting_3

time_travelling_3

time_spent_3

visit_fee_3

item_4

item_name_4

number_contact_4

money_travelling_4

time_waiting_4

time_travelling_4

time_spent_4

visit_fee_4

item_5

item_name_5

number_contact_5

money_travelling_5

time_waiting_5

time_travelling_5

time_spent_5

visit_fee_5

payment_in_kind

q2

q2a

q2b

q2p1

q2p1_1

q2p1_2

q2p1_3

q2p1_4

item_group_count

item_post_epiad_1

item_name_epiad_1

q2p1a_1

q2p1b_1

q2a_planned_1

q2p2

q2p2_1

q2p2_2

q2p2_3

q2p2_4

item_group_nonep_count

item_post_nonepi_1

item_name_nonepi_1

q2p2a_1

q2p2b_1

q2b_planned_1

item_post_nonepi_2

item_name_nonepi_2

q2p2a_2

q2p2b_2

q2b_planned_2

q3

q3p1a

q3p1a_1

q3p1a_2

q3p1a_3

q3p1a_4

rpt_testprovider_count

item_post_test_1

item_name_test_1

q3p1b_1

q3p1b_1_1

q3p1b_2_1

q3p1b_3_1

q3p1c_1

item_post_test_2

item_name_test_2

q3p1b_2

q3p1b_1_2

q3p1b_2_2

q3p1b_3_2

q3p1c_2

item_post_test_3

item_name_test_3

q3p1b_3

q3p1b_1_3

q3p1b_2_3

q3p1b_3_3

q3p1c_3

q4

q4p1a

q4p1a_1

q4p1a_2

q4p1a_3

q4p1a_4

q4p1a_5

q4p1a_6

q4p1a_7

q4p1a_8

q4p1a_9

q4p1a_10

q4p1a_11

q4p1a_96

q4p1a_96b

q4p1a_96c

q4p1a_96d

q4p1a_96e

q4p1a_tb

q4p1a_TB

q4p1a_drugs

q4p1a_epilim

q4p1a_Epilim

q4p1a_phenobabiton

q4p1a_Phenobabiton

q4p1a_chromo

q4p1a_Chromo

q4p1a_phenobabital

q4p1a_Phenobabital

q4p1a_carbamazepine

q4p1a_Carbamazepine

q4p1a_sp

q4p1a_sp_b

q4p1a_sp_c

q4p1a_sp_d

q4p1a_sp_e

rpt_medicines_count

item_post_drugs_1

item_name_drugs_1

item_name_drugdisp_1

q4p1b_1

q4p1b_1_1

q4p1b_2_1

q4p1c_1

q4p1d_1

q4p1d_total_ifdk_1

item_post_drugs_2

item_name_drugs_2

item_name_drugdisp_2

q4p1b_2

q4p1b_1_2

q4p1b_2_2

q4p1c_2

q4p1d_2

q4p1d_total_ifdk_2

item_post_drugs_3

item_name_drugs_3

item_name_drugdisp_3

q4p1b_3

q4p1b_1_3

q4p1b_2_3

q4p1c_3

q4p1d_3

q4p1d_total_ifdk_3

item_post_drugs_4

item_name_drugs_4

item_name_drugdisp_4

q4p1b_4

q4p1b_1_4

q4p1b_2_4

q4p1c_4

q4p1d_4

q4p1d_total_ifdk_4

item_post_drugs_5

item_name_drugs_5

item_name_drugdisp_5

q4p1b_5

q4p1b_1_5

q4p1b_2_5

q4p1c_5

q4p1d_5

q4p1d_total_ifdk_5

q5

q5p2a

q5p2a_days

q5p2b

q5p2b_days

q5p2c

q5p2c_days

q5p3

q5p3b

q5p4

q6a

q6b

q6c

q6a1

q6b1

q6c1

q7p1

q7p2

q7p3

q7p3_1

q7p3_2

q7p3_3

q7p3_4

q7p3_5

q7p3_6

q7p3_8

q7p3_9

q7p3_10

q7p3_11

q7p3_96

q7p3_7

q7p3_sp

q8p1

q8p2

q8p2_1

q8p2_2

q8p2_3

q8p2_96

q8p2_4

q8p2_specify

q8p3_1

q8p3_1_1

q8p3_1_2

q8p3_1_3

q8p3_1_4

q8p3_1_5

q8p3_1_6

q8p3_1_7

q8p3_1_8

q8p3_1_9

q8p3_1_96

q8p3_1_specify

q8p3

q8p4

q8p5

scr_q3p9

scr_q3p10

Total: 257